Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-10-07

FDA Approved: BUPROPION HYDROCHLORIDE XL — Supplemental Application (Epic Pharma, LLC)

View source ↗

Summary

FDA approved Epic Pharma's supplemental application for bupropion hydrochloride extended-release (XL), confirming the approval of a generic version of the antid…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bupropion hydrochloride extended-release (XL) (Bupropion hydrochloride)

Snippet

SUPPL AP for BUPROPION HYDROCHLORIDE XL (BUPROPION HYDROCHLORIDE)